Health experts have linked vaginal ring contraceptives like NuvaRing to higher blood clot rates than traditional birth control pills.
Kansas City, MO (PRWEB) August 20, 2013
The birth control safety advocates at DrugNews.net are announcing updated information for women using the contraceptive NuvaRing. A federal judge recently scheduled the start of the first trial for lawsuits alleging the device caused blood clot injuries*.
DrugNews provides the latest warnings, recalls, studies and legal news to patients using popular prescription drugs and devices. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Health experts have vaginal ring contraceptives like NuvaRing to higher blood clot rates than traditional birth control pills. Last year, the New England Journal of Medicine published a study suggesting they could result in a 2.5 to 3-fold increased risk of blood clots**.
Due to the number of women who have filed a NuvaRing lawsuit alleging blood clots, cases have been consolidated in a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. Court records show 1,296 cases are now pending***.
Now, DrugNews has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, recently entered an order scheduling the first trial to begin on January 27, 2014*.
Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugNews Resource Center or speak with a lawyer about their legal rights.
Due to the specialized nature of federal MDL drug injury cases, DrugNews only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*U.S. District Judge Rodney Sippel, 7/30/13; aboutlawsuits.com/wp-content/uploads/2013-07-30-NuvaRing-Order.pdf
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***JPML 7/10/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf